The ICMR-National Institute of Virology (NIV) in Pune has been at the forefront of scientific research on SARS-CoV-2 in the country. "2021 was a difficult but rewarding year for us", said Ms Priya Abraham, Director of ICMR-NIV in an interview with India Science, the OTT channel of the Department of Science & Technology....
Researchers at the Indian Institute of Science Education and Research (IISER) Bhopal have found the mechanism by which breast cancer cells proliferate and spread....
Despite causing a surge in infections that has resulted in thousands of hospitalisations and deaths, the Delta variant of Covid-19 is not particularly good at evading the antibodies generated by the Pfizer vaccine, according to a study. ...
The second mRNA Covid-19 Vaccine developed by German biopharmaceutical company CureVac and its British partner GlaxoSmithKline (GSK) has demonstrated improved immune response and protection than its first vaccine, according to a new study....
Indian researchers have developed a non-invasive, easy to administer, cost-effective and patient compliant potential therapeutic strategy against Visceral Leishmaniasis, a neglected tropical disease....
In a first-of-its kind in India, a team of researchers have conducted a study to examine the seasonal periodicities of airborne pollen spectrum and developed a pollen calendar for the city that can turn into big help for millions who suffer from related allergies....
Contracting Covid-19 infection during pregnancy can increase the risk of premature birth by 60 per cent....
We know that exercising is the best way to keep the body and mind fit and healthy. But exercise does more than that! It also acts as an immunity booster. The good news is that you do not have to do heavy exercises for long hours to strengthen your immune system....
Patients with Long Covid syndrome continue to have higher measures of blood clotting, which may help explain their persistent symptoms, such as reduced physical fitness and fatigue, finds a research. ...
A team of researchers has assessed the effectiveness of the T-cell immune response to 11 variants of SARS-CoV-2 and used their results to develop the T-cell Covid-19 Atlas portal (T-CoV). ...
